Literature DB >> 1265473

The serum half-life and urine concentrations of cephazolin sodium in patients with terminal renal failure: effect of haemodialysis.

J B Eastwood, P E Gower, J R Curtis.   

Abstract

The serum and plasma half-life of cephazolin has been determined in 5 maintenance haemodialysis patients during a non-dialysis period and then again in the same patients during haemodialysis with a Meltec Maxi-Multipont dialyser using cuprophance membranes. The mean half-life during the non-dialysis period was 28.3 hours and fell to a mean of 4.97 hours during haemodialysis. Percentage recovery of cephazolin in the urine was markedly reduced in 4 maintenance dialysis patients although adequate urine concentrations of cephazolin were achieved for many sensitive organisms. A dosage schedule for patients with creatinine clearances of less than 5 ml. per minute and for maintenance haemodialysis patients is suggested.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1265473     DOI: 10.1177/003693307502000513

Source DB:  PubMed          Journal:  Scott Med J        ISSN: 0036-9330            Impact factor:   0.729


  2 in total

1.  Editorial: Antibiotic treatment in kidneys of unequal function.

Authors: 
Journal:  Br Med J       Date:  1976-01-03

Review 2.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.